Predicting response and survival in chemotherapy-treated triple-negative breast cancer

BACKGROUND: In this study, we evaluated the ability of gene expression profiles to predict chemotherapy response and survival in triple-negative breast cancer (TNBC). METHODS: Gene expression and clinical–pathological data were evaluated in five independent cohorts, including three randomised clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200088/
https://www.ncbi.nlm.nih.gov/pubmed/25101563
http://dx.doi.org/10.1038/bjc.2014.444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200088/
https://www.ncbi.nlm.nih.gov/pubmed/25101563
http://dx.doi.org/10.1038/bjc.2014.444

Ejemplares similares